Gender difference in the incidence of shingles

被引:94
作者
Fleming, DM [1 ]
Cross, KW [1 ]
Cobb, WA [1 ]
Chapman, RS [1 ]
机构
[1] Royal Coll Gen Practitioners, Birmingham Res Unit, Birmingham B17 9DB, W Midlands, England
关键词
D O I
10.1017/S0950268803001523
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We investigated age- and gender-specific incidence of shingles reported in a large sentinel practice network monitoring a defined population over the years 1994-2001. In total, 5915 male and 8617 female incident cases were studied. For each age group, we calculated the relative risk of females to males presenting with shingles. Incidence rates of chickenpox and herpes simplex were examined similarly. Shingles incidence was greater in females in each age group (except for 15-24 years). Relative risks (female to male) were greatest in age groups 45-64 years (1.48) and 0-14 years (1.43). There were no gender differences in the incidence of chickenpox except in the 15-24 years age group (female excess): for herpes simplex there were female excesses in all age groups. Gender-specific age-standardized incidence rates of shingles were Calculated for each year and showed a consistent female excess in each of the 8 years (average annual excess 28%).
引用
收藏
页码:1 / 5
页数:5
相关论文
共 27 条
[1]   CELL-MEDIATED-IMMUNITY TO VARICELLA-ZOSTER VIRUS [J].
ARVIN, AM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 :S35-S41
[2]   RECURRENCE RATES IN GENITAL HERPES AFTER SYMPTOMATIC FIRST-EPISODE INFECTION [J].
BENEDETTI, J ;
COREY, L ;
ASHLEY, R .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (11) :847-854
[3]   The incidence of shingles and its implications for vaccination policy [J].
Chapman, RS ;
Cross, KW ;
Fleming, DM .
VACCINE, 2003, 21 (19-20) :2541-2547
[4]   Characteristics of patients with herpes zoster on presentation to practitioners in France [J].
Chidiac, C ;
Bruxelle, J ;
Daures, JP ;
Xuan, TH ;
Morel, P ;
Leplège, A ;
El Hasnaoui, A ;
de Labareyre, C .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (01) :62-69
[5]  
DONAHUE JG, 1995, ARCH INTERN MED, V155, P1603
[6]   The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales [J].
Edmunds, WJ ;
Brisson, M ;
Rose, JD .
VACCINE, 2001, 19 (23-24) :3076-3090
[7]  
*EUR, DEM STAT 1999
[8]  
FLEMING D, 1999, BIOM HLTH R, V35, P119
[9]  
Fleming D M, 1999, Commun Dis Public Health, V2, P96
[10]  
FLEMING DM, 1991, BR J GEN PRACT, V53, P5